ACH has been historically used in Chinese medicine for its therapeutic effects in treating acute and chronic hepatitis. It is commonly consumed in soup or tea in southern China.
In short, Abri Herba (Ji-Gu-Cao) has potential for treating liver diseases, but toxicity concerns need further research for safe clinical use. Investigate anti-hyperlipidaemia and hepatoprotective effects for NAFL treatment.
Abrus cantoniensis herb (ACS) is a Chinese medicine used for hepatitis treatment. It has protective effects on liver injuries, but its influence on drug-induced liver injury (DILI) remains unproven.
Researchers used network pharmacology to explore the mechanism behind Abrus cantoniensis, an herb used for antiepileptic treatment. Through various databases, they found three active components mainly related to -sitosterol and stigmasterol, 92 intersection targets of epilepsy including 9 core targets, and 8 core targets as flavanone constituent proteins. Additionally, they found that Abrus cantoniensis is mainly connected to epilepsy through the neuroactive ligand-receptor interaction signaling pathway, the neurodegeneration pathway, and multiple disease signaling pathway. The study provides a new strategy for antiepileptic treatment using Abrus cantoniensis.